Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • For Subscribers
    • For Advertisers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • For Subscribers
    • For Advertisers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleArticle

THE ANALEPTIC ACTION OF 1-n-BUTYLAMINO-3-p-TOLUIDINO-2-PROPANOL (W181) IN MEPHENESIN PARALYSIS

F. M. Berger
Journal of Pharmacology and Experimental Therapeutics February 1953, 107 (2) 250-257;
F. M. Berger
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

1-n-Butylamino-3-p-toluidino-2-propanol, called W181, possesses convulsant activity in similar doses as picrotoxin. W181 differs from picrotoxin in producing convulsions of greater violence, in possessing an even narrower margin between convulsant and lethal doses and in not causing delayed convulsions.

W181 is the only known drug that can arouse animals from paralysis caused by mephenesin. W181 is however ineffective in saving the lives of animals which have received lethal doses of mephenesin.

W181 has a marked analeptic action in pentobarbital anesthesia and is in this respect only slightly inferior to picrotoxin. W181 is also effective, but very much less so than picrotoxin, in counteracting the effects of a lethal dose of pentobarbital.

W181 appears unsuitable for the production of therapeutic convulsions in humans because of the narrow margin between convulsant and lethal doses. It would also be inadvisable to use this potent and dangerous drug climcally after an overdose of mephenesin because spontaneous recovery is likely even after ingestion of very large doses of mephenesin.

Footnotes

    • Received October 22, 1952.

Log in using your username and password

Forgot your user name or password?

Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$35.00

Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.

PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 107, Issue 2
1 Feb 1953
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
THE ANALEPTIC ACTION OF 1-n-BUTYLAMINO-3-p-TOLUIDINO-2-PROPANOL (W181) IN MEPHENESIN PARALYSIS
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
Citation Tools
Research ArticleArticle

THE ANALEPTIC ACTION OF 1-n-BUTYLAMINO-3-p-TOLUIDINO-2-PROPANOL (W181) IN MEPHENESIN PARALYSIS

F. M. Berger
Journal of Pharmacology and Experimental Therapeutics February 1, 1953, 107 (2) 250-257;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

THE ANALEPTIC ACTION OF 1-n-BUTYLAMINO-3-p-TOLUIDINO-2-PROPANOL (W181) IN MEPHENESIN PARALYSIS

F. M. Berger
Journal of Pharmacology and Experimental Therapeutics February 1, 1953, 107 (2) 250-257;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • CRV431 Decreases Liver Fibrosis and Tumor Development
  • Pharmacological Characterization of Nicotine-Induced Seizures in Mice
  • Desensitization of Nicotinic Agonist-Induced [3H]γ-Aminobutyric Acid Release from Mouse Brain Synaptosomes Is Produced by Subactivating Concentrations of Agonists
Show more Article

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2019 by the American Society for Pharmacology and Experimental Therapeutics